Tag: Health care industry

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

September 5, 2024 Admin No Comments

A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Earlier this…

Health

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

August 20, 2024 Admin No Comments

Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday. The late-stage trial on tirzepatide, the active ingredient in the company’s weight loss injection Zepbound and diabetes…

Health

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

August 2, 2024 Admin No Comments

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug…

Health

Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test

July 18, 2024 Admin No Comments

Dr. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is a CNBC contributor and is a member of the boards of Pfizer and several other startups in health and tech. He is also a partner at the venture capital firm New Enterprise Associates. Shani…

Health

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

June 28, 2024 Admin No Comments

Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC. A day earlier, the pharmaceutical giant’s stock had closed 6% higher after its…

Health

FDA approves two new Abbott over-the-counter continuous glucose monitors

June 10, 2024 Admin No Comments

Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring…

Health

Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

May 22, 2024 Admin No Comments

Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multiyear program to reduce costs as it works to rebound from the rapid decline of its Covid business. The announcement is in addition…

Health

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

May 3, 2024 Admin No Comments

Amgen‘s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new competition in the rapidly growing weight loss drug industry, sending shares of the current obesity players, Novo Nordisk and Eli Lilly, lower on Friday. Eli Lilly shares dropped…

Health

Health records giant Epic cracks down on startup for unauthorized sharing of patient data

April 13, 2024 Admin No Comments

The eponymous sign outside Epic headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC Epic Systems, the largest provider of software for managing medical records, says a venture-backed startup called Particle Health is using patient data in unauthorized and unethical ways that have nothing to do with treatment. Epic told customers in a notice on…

Health

FDA approves Merck’s drug for rare, deadly lung condition

March 26, 2024 Admin No Comments

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults with pulmonary arterial hypertension. The decision…

Health